488
Participants
Start Date
June 22, 2024
Primary Completion Date
June 20, 2026
Study Completion Date
June 20, 2026
Methylene Blue Intervention Group
In addition to standard treatment, patients will receive methylene blue intervention. The method is as follows: a loading dose of 2.5 mg/kg administered via micro-pump over 15 minutes, followed by a continuous infusion at a rate of 0.25 mg/kg/hour for 12 hours or until norepinephrine has been continuously discontinued for 4 hours, whichever comes first. If norepinephrine needs to be increased to 0.1 μg/kg/min before the 12-hour period ends, continue using methylene blue until the 12-hour infusion is completed.
Normal Saline Control Group
In addition to standard treatment, patients will receive a placebo control with normal saline, administered for the same duration as the intervention group.
RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Yuyao People's Hospital
OTHER
Taizhou Enze Medical Center Group
OTHER
NINGBO MEDICAL CENTER LIHUIIHOSPITAI
UNKNOWN
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
The second Nanning People's Hospital
UNKNOWN
GUI LIN PEOPLE'S HOSPITAL
UNKNOWN
Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University
UNKNOWN
The First People's Hospital of Huzhou
OTHER
Hangzhou Yuhang District Second People's Hospital
UNKNOWN
Wuming Hospital of Guangxi Medical University
UNKNOWN
First Affiliated Hospital of Zhejiang University
OTHER